Clinical inputs
Understand the result,
not just the number.
CRUSADE Bleeding Score: Explanation and Clinical Context The CRUSADE Bleeding Score is a validated tool designed to predict in-hospital major bleeding risk for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) undergoing antithrombotic therapy or percutaneous coronary intervention. It incorporates baseline clinical and laboratory variables such as hematocrit, creatinine clearance, heart rate, systolic blood pressure, sex, presence of heart failure, prior vascular disease, and diabetes. Patients are stratified into very low, low, moderate, high, or very high risk categories for major bleeding, which can guide clinicians in tailoring antithrombotic therapy and peri-procedural care.
- Source 1
Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non–ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score. Circulation. 2009;119:1873–1882. doi:10.1161/CIRCULATIONAHA.108.807082
Loading discussion…